Varex Imaging will be acquired by Teledyne Technologies for $18.90 per share, amounting to roughly $1.1 billion. This significant premium underscores investor confidence in the merger, which is expected to accelerate growth opportunities across the X-ray technology sector.

Key Highlights

  • This marks a substantial opportunity for shareholders, providing a noteworthy premium that reflects the value of Varex’s advanced imaging technologies.
  • The Acquisition comes as Varex has demonstrated a strong performance, with its shares up 58.5% year-to-date and 67.1% over the past month.
  • Varex and Teledyne anticipate that the closing of the Merger will take place in early 2027, subject to customary closing conditions including regulatory and stockholder approvals.

Teledyne's acquisition of Varex Imaging at $18.90 per share marks a substantial opportunity for shareholders, providing a noteworthy premium that reflects the value of Varex’s advanced imaging technologies. Teledyne's decision to execute this merger showcases a strategic shift within the medical imaging sector, aiming to consolidate expertise and resources that will be imperative for future growth as healthcare demands evolve.

Acquisition Terms Detailed Under the terms of the merger agreement, all outstanding shares of Varex will automatically convert into cash at the $18.90 rate, with certain exceptions for dissenting, treasury shares, and shares owned by subsidiaries. The merger received unanimous approval from both companies' boards, indicating strong confidence in the benefits of combining their varied product offerings and positions in the healthcare technology market. Investors should monitor Varex's stockholder approval process at the forthcoming special meeting, as this will be key in moving the transaction forward.

Significance for Investors The acquisition comes as Varex has demonstrated a strong performance, with its shares up 58.5% year-to-date and 67.1% over the past month. Varex offers an extensive portfolio in X-ray technologies that aligns well with Teledyne’s existing operations, creating a pathway for enhanced market penetration and product innovation. The merger addresses ongoing Demand and technological advancements in the medical imaging sector, enhancing potential Cash Flow and profitability post-merger, key elements that investors are keen to evaluate in the coming months.

Keeping an Eye on Key Dates Varex and Teledyne anticipate that the closing of the merger will take place in early 2027, subject to customary closing conditions including regulatory and stockholder approvals. As part of the merger agreement, Varex is responsible for convening a special meeting to secure stockholder consent. That meeting is central to progressing with the merger and will require close attention from investors.

Investor Insights

The preparations for the proxy statement and subsequent approvals are significant immediate steps that shareholders and Market Participants should track, laying the groundwork for this consequential transaction in the imaging environment.

Peers Moving on This News

  • Shoulder Innovations Inc (SI) little changed
  • Clearpoint Neuro Inc (CLPT) down 0.3%
  • Neuropace Inc (NPCE) little changed

Analysis based on the Form 8-K filed 10 August 2026; figures verified against the filing and live market data.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making Investment decisions.